Literature DB >> 29236572

Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data.

Christopher M Booth1, Safiya Karim1, Yingwei Peng1, D Robert Siemens1, Kelly Brennan1, William J Mackillop1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29236572     DOI： 10.1200/JCO.2017.76.1759

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Another dimension to the understanding of local therapy for metastatic prostate cancer.

Authors:  Michael Leveridge; Robert J Hamilton
Journal:  Can Urol Assoc J       Date:  2019-06       Impact factor: 1.862

2.  Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.

Authors:  Mark Warren; Michael Kolinsky; Christina M Canil; Piotr Czaykowski; Srikala S Sridhar; Peter C Black; Christopher M Booth; Wassim Kassouf; Libni Eapen; Som D Mukherjee; Normand Blais; Bernhard J Eigl; Eric Winquist; Naveen S Basappa; Scott A North
Journal:  Can Urol Assoc J       Date:  2019-04-26       Impact factor: 1.862

3.  The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells.

Authors:  Hong-Qing Zhou; Ming-Sheng Liu; Ti-Bin Deng; Ping-Bo Xie; Wei Wang; Tao Shao; Yao Wu; Peng Zhang
Journal:  Onco Targets Ther       Date:  2019-09-23       Impact factor: 4.147

4.  Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial.

Authors:  Yukihide Kanemitsu; Kohei Shitara; Junki Mizusawa; Tetsuya Hamaguchi; Dai Shida; Koji Komori; Satoshi Ikeda; Hitoshi Ojima; Hideyuki Ike; Akio Shiomi; Jun Watanabe; Yasumasa Takii; Takashi Yamaguchi; Kenji Katsumata; Masaaki Ito; Junji Okuda; Ryoji Hyakudomi; Yasuhiro Shimada; Hiroshi Katayama; Haruhiko Fukuda
Journal:  J Clin Oncol       Date:  2021-02-09       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.